The Diabetes, Obesity and Metabolism Institute made further outstanding progress in 2023 in the study of diabetes, obesity, and metabolic syndromes. The Institute continued its pioneering research in beta cell regeneration and a rising cohort of physician-scientists made strides in basic and translational science.